I sent the below questions via the investor relation page on the Dotz website to Ian Pamansky a few days ago, still got no reply. Does anyone know how to reach them?
According to the FDA website, is our product classified as a class 2 medical device? If yes, FDA is required to respond to complete 510(k) submission within 60 days of receipt. Has the company received such notification?
Does the company have the intention to apply for TGA in Australia?
I sent the below questions via the investor relation page on the...
Add DTZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $67.85M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 12.0¢ | $11.59K | 93.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 44218 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.5¢ | 12.0¢ | 49369 | ||
| Last updated 15.22pm 06/05/2024 ? | |||||
| DTZ (ASX) Chart |